Meng Yuan Selected Research

Atrial Remodeling

9/2022	Improving effects of eplerenone on atrial remodeling induced by chronic intermittent hypoxia in rats.
1/2022	IP3R1/GRP75/VDAC1 complex mediates endoplasmic reticulum stress-mitochondrial oxidative stress in diabetic atrial remodeling.
1/2022	Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling.
5/2021	Activation of NADPH oxidase mediates mitochondrial oxidative stress and atrial remodeling in diabetic rabbits.
1/2021	Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway.
1/2020	Wenxin Keli Regulates Mitochondrial Oxidative Stress and Homeostasis and Improves Atrial Remodeling in Diabetic Rats.
1/2019	Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice.
12/2018	Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats.
8/2018	Doxycycline Attenuates Atrial Remodeling by Interfering with MicroRNA-21 and Downstream Phosphatase and Tensin Homolog (PTEN)/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meng Yuan Research Topics

Disease

34	Neoplasms (Cancer) 07/2022 - 01/2016
30	COVID-19 07/2022 - 01/2020
27	Infections 03/2022 - 05/2009
12	Fibrosis (Cirrhosis) 09/2022 - 01/2016
9	Atrial Remodeling 09/2022 - 08/2018
7	Hypoxia (Hypoxemia) 09/2022 - 06/2018
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2017
7	Inflammation (Inflammations) 06/2021 - 01/2018
6	Disease Resistance 01/2022 - 02/2006
5	Atrial Fibrillation 06/2022 - 01/2018
5	Carcinogenesis 03/2022 - 01/2017
4	Wounds and Injuries (Trauma) 12/2022 - 09/2021
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2020
4	Hypertension (High Blood Pressure) 12/2021 - 01/2018
4	Atherosclerosis 01/2019 - 06/2015
3	Seizures (Absence Seizure) 05/2022 - 10/2021
3	Heart Failure 01/2022 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2017
3	Necrosis 01/2022 - 02/2016
3	Carcinoma (Carcinomatosis) 01/2022 - 01/2020
3	Virus Diseases (Viral Diseases) 10/2021 - 01/2021
3	Atrophy 01/2021 - 12/2019
3	Neuromyelitis Optica (Devic's Disease) 01/2021 - 01/2020
3	Acute Lung Injury 01/2020 - 01/2019
3	Stroke (Strokes) 10/2019 - 01/2018
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 06/2015
2	Disease Progression 12/2022 - 07/2021
2	Aplastic Anemia (Anemia, Hypoplastic) 11/2022 - 01/2022
2	Adenocarcinoma 07/2022 - 10/2020
2	Lymphedema (Milroy Disease) 06/2022 - 04/2020
2	Liver Neoplasms (Liver Cancer) 03/2022 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 10/2021
2	Epilepsy (Aura) 03/2022 - 08/2021
2	Human Influenza (Influenza) 01/2022 - 11/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 12/2020
2	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2018
2	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 01/2020
2	Genomic Instability 07/2021 - 01/2021
2	Leukemia 07/2021 - 10/2019
2	Diabetes Mellitus 05/2021 - 01/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 05/2018
2	Myocardial Infarction 01/2021 - 01/2019
2	Muscular Atrophy (Muscle Atrophy) 01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 07/2022 - 05/2009
11	VaccinesIBA 01/2022 - 01/2020
11	AntibodiesIBA 01/2022 - 08/2020
10	Pharmaceutical PreparationsIBA 12/2022 - 04/2020
9	Monoclonal AntibodiesIBA 04/2022 - 07/2020
8	Neutralizing AntibodiesIBA 03/2022 - 07/2020
6	Transcription Factors (Transcription Factor)IBA 03/2022 - 01/2016
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2020
5	Broadly Neutralizing AntibodiesIBA 02/2022 - 02/2021
4	Small Interfering RNA (siRNA)IBA 04/2022 - 01/2019
4	Biological ProductsIBA 03/2022 - 08/2018
4	EpitopesIBA 02/2022 - 08/2020
4	EnzymesIBA 02/2022 - 01/2022
4	Messenger RNA (mRNA)IBA 01/2020 - 04/2016
3	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2020
3	CollagenIBA 07/2022 - 09/2021
3	Levetiracetam (Keppra)FDA LinkGeneric 05/2022 - 10/2021
3	Therapeutic UsesIBA 03/2022 - 01/2021
3	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 01/2019
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 01/2019
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 08/2018
3	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2019
3	MetalsIBA 01/2022 - 09/2021
3	LipidsIBA 11/2021 - 06/2015
3	CholesterolIBA 11/2021 - 01/2018
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021 - 08/2018
3	Protein Kinases (Protein Kinase)IBA 01/2021 - 12/2018
3	CytokinesIBA 04/2020 - 01/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2018
2	Ion Channels (Ion Channel)IBA 09/2022 - 01/2020
2	Aldehyde DehydrogenaseIBA 07/2022 - 01/2019
2	Antiviral Agents (Antivirals)IBA 07/2022 - 09/2019
2	RNA (Ribonucleic Acid)IBA 06/2022 - 01/2020
2	Anticonvulsants (Antiepileptic Drugs)IBA 05/2022 - 08/2021
2	Peptides (Polypeptides)IBA 04/2022 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 12/2021
2	AntioxidantsIBA 02/2022 - 01/2019
2	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 11/2021
2	Glutathione (Reduced Glutathione)IBA 01/2022 - 10/2021
2	AntigensIBA 01/2022 - 11/2021
2	SARS-CoV-2 spike proteinIBA 01/2022 - 01/2022
2	Bispecific AntibodiesIBA 10/2021 - 04/2021
2	Acetylcysteine (Siran)FDA LinkGeneric 10/2021 - 02/2016
2	Valsartan (Vals)FDA Link 09/2021 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2021
2	Interferon Type IIBA 01/2021 - 01/2021
2	DiterpenesIBA 01/2021 - 12/2020

Therapy/Procedure

27	Therapeutics 07/2022 - 01/2019
12	Radiotherapy 01/2022 - 01/2016
6	Drug Therapy (Chemotherapy) 04/2022 - 05/2017
3	Neoadjuvant Therapy 01/2022 - 01/2020
2	Hematopoietic Stem Cell Transplantation 11/2022 - 01/2022
2	Precision Medicine 04/2022 - 03/2022
2	Chemoradiotherapy 12/2021 - 01/2019
2	Photochemotherapy (Photodynamic Therapy) 06/2021 - 10/2019
2	Critical Care (Surgical Intensive Care) 04/2021 - 07/2020
2	Denervation 01/2021 - 01/2020